Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CPHD
Morning Market Losers
Benzinga's Top Downgrades
Related ABT
Benzinga's M&A Chatter for Thursday August 27, 2015
Benzinga's Volume Movers
Can Top 10 Healthcare Dogs Average 25% Upsides And 27% Net Gains As Of September 2016? (Seeking Alpha)

Analysts at Piper Jaffray downgraded Cepheid (NASDAQ: CPHD) from “overweight” to “neutral.” Cepheid's shares closed at $34.09 yesterday. Cepheid's trailing-twelve-month ROE is -12.52%.

Analysts at Deutsche Bank downgraded Abbott Laboratories (NYSE: ABT) from “buy” to “hold.” Abbott's shares closed at $33.27 yesterday. Abbott's PEG ratio is 0.51.

Analysts at Goldman Sachs downgraded Wells Fargo & Company (NYSE: WFC) from “buy” to “neutral.” Wells Fargo's shares closed at $34.76 yesterday. Wells Fargo's trailing-twelve-month profit margin is 23.18%.

Raymond James downgraded First Solar (NASDAQ: FSLR) from “market perform” to “underperform.” First Solar's shares closed at $34.41 yesterday. First Solar's trailing-twelve-month ROA is 2.17%.

Latest Ratings for CPHD

DateFirmActionFromTo
Jul 2015Evercore PartnersDowngradesHoldSell
Jun 2015Craig-HallumUpgradesHoldBuy
Apr 2015JMP SecuritiesMaintainsMarket Outperform

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CPHD + ABT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters